. "Bates, D." . "Havrdov\u00E1, Eva" . "RIV/00216208:11110/09:3950!RIV10-MSM-11110___" . "1474-4422" . "000263711200015" . . . "Kim, R." . "Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study"@en . "11110" . "Lublin, FD" . "Hyde, R." . . "[50870E4366AC]" . . "RIV/00216208:11110/09:3950" . . . "Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study" . "312186" . "Galetta, S." . "13"^^ . . "Hutchinson, M." . . . "Lancet Neurology" . . "Giovannoni, G." . . "The efficacy of natalizumab on clinical and radiological measures in the phase III Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study has prompted the investigation of whether natalizumab can increase the proportion of patients with relapsing-remitting multiple sclerosis who do not have disease activity." . "Placebo-controlled trial; double-blind; rheumatoid-arthritis; multicenter; disability; methotrexate"@en . . "Polman, C. H." . "Phillips, JT" . "8" . . "3" . "Z(MSM0021620849)" . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . "O'Connor, PW" . . "1"^^ . . "The efficacy of natalizumab on clinical and radiological measures in the phase III Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study has prompted the investigation of whether natalizumab can increase the proportion of patients with relapsing-remitting multiple sclerosis who do not have disease activity."@en . "Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study"@en . "Pace, A." . "7"^^ . . "Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study" . "Stefoski, D." .